[go: up one dir, main page]

AU2002361117A1 - 5-membered cyclic compounds - Google Patents

5-membered cyclic compounds

Info

Publication number
AU2002361117A1
AU2002361117A1 AU2002361117A AU2002361117A AU2002361117A1 AU 2002361117 A1 AU2002361117 A1 AU 2002361117A1 AU 2002361117 A AU2002361117 A AU 2002361117A AU 2002361117 A AU2002361117 A AU 2002361117A AU 2002361117 A1 AU2002361117 A1 AU 2002361117A1
Authority
AU
Australia
Prior art keywords
membered cyclic
cyclic compounds
compounds
membered
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002361117A
Inventor
Fujio Antoku
Norio Fujiwara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2002361117A1 publication Critical patent/AU2002361117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002361117A 2001-12-28 2002-12-26 5-membered cyclic compounds Abandoned AU2002361117A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001401397 2001-12-28
JP2001-401397 2001-12-28
PCT/JP2002/013725 WO2003057693A1 (en) 2001-12-28 2002-12-26 5-membered cyclic compounds

Publications (1)

Publication Number Publication Date
AU2002361117A1 true AU2002361117A1 (en) 2003-07-24

Family

ID=19189769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002361117A Abandoned AU2002361117A1 (en) 2001-12-28 2002-12-26 5-membered cyclic compounds

Country Status (2)

Country Link
AU (1) AU2002361117A1 (en)
WO (1) WO2003057693A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101278011B1 (en) 2005-04-28 2013-06-27 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Therapeutic agent for chronic obstructive pulmonary disease
WO2007140439A2 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Compounds as cannabinoid receptor ligands and uses thereof
BRPI0712720A2 (en) * 2006-05-31 2012-11-20 Abbott Lab thiazide compounds as cannabinoid receptor ligands and uses thereof
EP2042492A1 (en) * 2007-09-26 2009-04-01 Bayer CropScience AG Novel Iminooxazole and Iminothiazole Compounds
WO2009131170A1 (en) 2008-04-25 2009-10-29 大日本住友製薬株式会社 Five-membered ring compound
KR20100134688A (en) 2008-04-25 2010-12-23 다이닛본 스미토모 세이야꾸 가부시끼가이샤 Novel 5-membered Ring Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000092A (en) * 1991-06-21 1993-01-25 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
US6919361B2 (en) * 2000-06-30 2005-07-19 Sumitomo Pharmaceuticals Company, Limited Five-membered-ring compound

Also Published As

Publication number Publication date
WO2003057693A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
AU2001241142A1 (en) Cyclic compounds
AU2002349297A1 (en) Statin-like compounds
AU2002323787A1 (en) Spiro compounds
AUPR419701A0 (en) An improved backpack
AU2002359919A1 (en) Syringe
AU2002360487A1 (en) Acyclovir-peptide analogs
AU2002361092A1 (en) Syringe
AU2002359165A1 (en) Novel compounds
AUPR878201A0 (en) New compounds
AU2002328576A1 (en) Cyclic amine compound
EP1394166A3 (en) Organosilicon Compounds
AU2002361117A1 (en) 5-membered cyclic compounds
AUPR755501A0 (en) Cyclic compound
AU2002349142A1 (en) Syringe
AUPR920301A0 (en) Neurologically-active compounds
AUPQ575100A0 (en) Cyclic compound
AUPQ860300A0 (en) Cyclic compound
AU1871101A (en) Cyclic compound
AU2004201666B2 (en) 4-Imidazolin-2-one compounds
AU2002251553A1 (en) Heterocyclic compounds
AU2002337136A1 (en) Isocyanato-isocyano compounds
AU2002363108A1 (en) 4-imidazolin-2-one compounds
AU2002306300A1 (en) Azasugar compounds
AU2002235881A1 (en) Compounds
HK1061033A (en) Novel compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase